Daewoong Pharma (069620) — Strategic Asset Allocation Index
Daewoong Pharma (069620) has a Strategic Asset Allocation Index of 55.7% as of June 2023. Strategic assets (PP&E of ₩459.49 Billion plus long-term investments of ₩-) total ₩459.49 Billion, measured against net assets of ₩824.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Daewoong Pharma balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Daewoong Pharma Strategic Asset Allocation Index (2007–2022)
This chart shows how Daewoong Pharma's Strategic Asset Allocation Index has evolved across 14 annual periods from 2007 to 2022. As of June 2023, the index stands at 55.7%, representing strategic assets of ₩459.49 Billion against net assets of ₩824.97 Billion KRW. For live market cap and overall valuation, see Daewoong Pharma stock valuation.
Annual Strategic Asset Allocation Index for Daewoong Pharma (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Daewoong Pharma from 2007 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Daewoong Pharma's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 59.5% | ₩440.89 Billion | ₩440.89 Billion | ₩- | ₩741.22 Billion | ▲ +3.1 pp |
| 2021 | 56.4% | ₩395.87 Billion | ₩395.87 Billion | ₩- | ₩702.41 Billion | ▼ -0.3 pp |
| 2020 | 56.6% | ₩393.69 Billion | ₩393.69 Billion | ₩- | ₩695.25 Billion | ▼ -10.0 pp |
| 2019 | 66.7% | ₩423.85 Billion | ₩391.71 Billion | ₩32.14 Billion | ₩635.92 Billion | ▼ -2.3 pp |
| 2018 | 69.0% | ₩419.25 Billion | ₩401.13 Billion | ₩18.12 Billion | ₩607.81 Billion | ▲ +5.0 pp |
| 2017 | 64.0% | ₩404.20 Billion | ₩396.16 Billion | ₩8.05 Billion | ₩631.54 Billion | ▲ +1.8 pp |
| 2016 | 62.2% | ₩375.75 Billion | ₩367.08 Billion | ₩8.67 Billion | ₩604.55 Billion | ▲ +16.3 pp |
| 2015 | 45.9% | ₩266.11 Billion | ₩255.84 Billion | ₩10.26 Billion | ₩580.24 Billion | ▲ +8.0 pp |
| 2014 | 37.8% | ₩172.36 Billion | ₩160.11 Billion | ₩12.25 Billion | ₩455.51 Billion | ▲ +3.7 pp |
| 2013 | 34.1% | ₩149.36 Billion | ₩132.62 Billion | ₩16.74 Billion | ₩437.96 Billion | ▲ +4.4 pp |
| 2012 | 29.7% | ₩114.86 Billion | ₩114.86 Billion | ₩- | ₩386.59 Billion | ▼ -0.1 pp |
| 2011 | 29.8% | ₩107.97 Billion | ₩107.97 Billion | ₩- | ₩362.42 Billion | ▼ -19.7 pp |
| 2008 | 49.5% | ₩138.06 Billion | ₩138.06 Billion | ₩- | ₩278.85 Billion | ▲ +6.7 pp |
| 2007 | 42.8% | ₩115.42 Billion | ₩115.42 Billion | ₩- | ₩269.57 Billion | — |